Table 2 |
||||||||
|
Differences in disease activity measures between females and males in the QUEST-RA Study according to the number of swollen joints |
||||||||
| Number of swollen joints |
Mean (standard deviation) |
|||||||
|
|
||||||||
| DAS28 |
TJC28 |
ESR |
MD global |
Pain |
Patient global |
Fatigue |
HAQ |
|
|
|
||||||||
| 0–1 |
||||||||
| Female |
3.2 (1.2) |
3.2 (5.3) |
24 (19) |
1.6 (1.8) |
3.3 (2.6) |
3.3 (2.5) |
3.9 (2.9) |
0.83 (0.75) |
| Male |
2.7 (1.2) |
2.0 (3.9) |
20 (21) |
1.2 (1.5) |
2.6 (2.5) |
2.9 (2.6) |
2.9 (2.7) |
0.52 (0.62) |
| P value |
<0.001 |
<0.001 |
<0.001 |
<0.001 |
<0.001 |
<0.001 |
<0.001 |
<0.001 |
| 2–3 |
||||||||
| Female |
4.2 (1.1) |
5.2 (5.4) |
29 (22) |
2.8 (1.9) |
4.1 (2.6) |
4.1 (2.4) |
4.5 (2.8) |
1.1 (0.71) |
| Male |
3.8 (1.2) |
4.7 (5.7) |
25 (26) |
2.4 (1.8) |
3.6 (2.4) |
3.6 (2.3) |
3.7 (2.6) |
0.74 (0.62) |
| P value |
<0.001 |
0.26 |
0.11 |
0.013 |
0.010 |
0.010 |
0.001 |
<0.001 |
| 4–6 |
||||||||
| Female |
4.8 (1.1) |
7.3 (6.0) |
31 (23) |
3.5 (2.0) |
4.7 (2.5) |
4.6 (2.4) |
5.0 (2.7) |
1.2 (0.71) |
| Male |
4.6 (1.3) |
6.8 (6.2) |
32 (27) |
3.4 (2.0) |
4.1 (2.5) |
4.4 (2.4) |
4.2 (2.7) |
0.91 (0.64) |
| P value |
0.071 |
0.28 |
0.63 |
0.041 |
0.017 |
0.29 |
<0.001 |
<0.001 |
| ≥ 7 |
||||||||
| Female |
6.0 (1.2) |
13 (8.0) |
38 (25) |
5.1 (2.1) |
5.6 (2.5) |
5.2 (2.5) |
5.6 (2.6) |
1.4 (0.75) |
| Male |
5.8 (1.3) |
12 (7.8) |
38 (28) |
4.9 (2.1) |
5.2 (2.3) |
4.9 (2.4) |
5.0 (2.6) |
1.2 (0.68) |
| P value |
0.016 |
0.064 |
0.99 |
0.21 |
0.024 |
0.082 |
<0.001 |
<0.001 |
|
|
||||||||
|
P values are from Student t test for independent samples. DAS28, disease activity score using 28 joint counts; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire; MD global, doctor global assessment; QUEST-RA, Quantitative Standard Monitoring of Rheumatoid Arthritis; TJC28, tender joint count-28. |
||||||||
|
Sokka et al. Arthritis Research & Therapy 2009 11:R7 doi:10.1186/ar2591 |
||||||||